Oren Ilan's most recent trade in Roivant Sciences Ltd was a trade of 2,296 Common Shares done . Disclosure was reported to the exchange on July 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2025 | 2,296 | 104,796 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.65 per share. | 17 Jul 2025 | 115 | 104,681 | - | 11.7 | 1,340 | Common Shares |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 2,635 | 102,564 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.16 per share. | 17 Apr 2025 | 64 | 102,500 | - | 10.2 | 650 | Common Shares |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 2,386 | 100,242 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.21 per share. | 23 Jan 2025 | 313 | 99,929 | - | 11.2 | 3,509 | Common Shares |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2024 | 2,303 | 97,856 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Other type of transaction at price $ 12.12 per share. | 12 Sep 2024 | 3,487 | 95,553 | - | 12.1 | 42,262 | Common Shares |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 27,894 | 27,894 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2024 | 16,406 | 99,040 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2024 | 2,440 | 82,849 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.01 per share. | 23 Jul 2024 | 215 | 82,634 | - | 11.0 | 2,367 | Common Shares |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 2,121 | 80,463 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.91 per share. | 24 Apr 2024 | 54 | 80,409 | - | 10.9 | 589 | Common Shares |
| Roivant Sciences Ltd | Oren Ilan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 3,366 | 78,342 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 1,472 | 63,585 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 1,942 | 62,113 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 2,010 | 60,171 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 2,796 | 58,161 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 71,850 | 71,850 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 52,142 | 55,365 | - | 0 | Common Shares | |
| Roivant Sciences Ltd | Ilan Oren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 3,223 | 3,223 | - | 0 | Common Shares |